Aflac’s dual-engine (Japan margin expansion + U.S. worksite scale) and relentless capital returns are driving per-share durability—even as FX and GAAP investment swings distort headline results.
Overview
Q1’26 results highlight the difference between Aflac’s **volatile GAAP optics** and its steadier core franchise. Reported revenue and net income surged primarily due to a swing from large prior-year investment losses to modest gains, masking the reality that **adjusted earnings were essentially flat to slightly down**. Nonetheless, adjusted EPS improved because Aflac continues to aggressively repurchase shares, concentrating earnings per share. Operationally, Japan delivered meaningful margin expansion (mid-30% pretax adjusted margin) despite premium runoff, driven by underwriting and a product mix shift toward third-sector health lines. The U.S. segment posted steady premium growth and stable profitability, supported by strong persistency and expanding product breadth. Capital strength remains high (robust RBC/ESR and target leverage), enabling continued dividends and buybacks. Key items to monitor include FX sensitivity, variable investment income volatility, cyber remediation progress, and long-term CEO succession planning.